TipRanks
Advertisement
Advertisement

DE:2EB0 Stock Latest News

Quoin Pharmaceuticals registers to sell 9.37M ADRs for holders
The FlyQuoin Pharmaceuticals registers to sell 9.37M ADRs for holders
5h ago
QNRX
Quoin Pharmaceuticals Gains FDA Rare Pediatric Designation
PremiumCompany Announcements
Quoin Pharmaceuticals Gains FDA Rare Pediatric Designation
8d ago
8K
QNRX
Quoin Pharmaceuticals granted Rare Pediatric Disease Designation for QRX003
PremiumThe Fly
Quoin Pharmaceuticals granted Rare Pediatric Disease Designation for QRX003
11d ago
QNRX
Quoin Reports Positive Interim QRX003 Netherton Data
PremiumCompany Announcements
Quoin Reports Positive Interim QRX003 Netherton Data
21d ago
8K
QNRX
Quoin Pharmaceuticals announces $50M private placement
PremiumThe Fly
Quoin Pharmaceuticals announces $50M private placement
22d ago
QNRX
Quoin Pharmaceuticals reports ‘positive’ data from Phase 2/3 study of QRX003
PremiumThe FlyQuoin Pharmaceuticals reports ‘positive’ data from Phase 2/3 study of QRX003
22d ago
QNRX
Quoin Pharmaceuticals Shareholders Approve Governance and Compensation Changes
Premium
Company Announcements
Quoin Pharmaceuticals Shareholders Approve Governance and Compensation Changes
29d ago
8K
QNRX
Quoin Pharmaceuticals reports Q2 EPS ($1.90), consensus ($1.77)
Premium
The Fly
Quoin Pharmaceuticals reports Q2 EPS ($1.90), consensus ($1.77)
1M ago
QNRX
QNRX Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
QNRX Upcoming Earnings Report: What to Expect?
1M ago
QNRX
Quoin Pharmaceuticals announces FDA clearance of QRX003 IND application
PremiumThe Fly
Quoin Pharmaceuticals announces FDA clearance of QRX003 IND application
2M ago
QNRX
Quoin Pharmaceuticals receives notice of allowance for QRX003 patent
PremiumThe Fly
Quoin Pharmaceuticals receives notice of allowance for QRX003 patent
3M ago
QNRX
Naz Rahman Maintains Buy on Quoin as QYLEKI Progress Offsets Financing Risks, While Cutting 12-Month Price Target from $40 to $16
PremiumRatings
Naz Rahman Maintains Buy on Quoin as QYLEKI Progress Offsets Financing Risks, While Cutting 12-Month Price Target from $40 to $16
3M ago
QNRX
Quoin Advances QYLEKI Toward First Netherton Therapy
PremiumCompany AnnouncementsQuoin Advances QYLEKI Toward First Netherton Therapy
3M ago
8K
QNRX
Quoin Pharmaceuticals announces conditional FDA approval for Qyleki brand name
Premium
The Fly
Quoin Pharmaceuticals announces conditional FDA approval for Qyleki brand name
3M ago
QNRX
Quoin Pharmaceuticals completes establishment of subsidiary in Japan
Premium
The Fly
Quoin Pharmaceuticals completes establishment of subsidiary in Japan
3M ago
QNRX
Quoin reports positive pediatric data in Netherton Syndrome program
PremiumThe Fly
Quoin reports positive pediatric data in Netherton Syndrome program
3M ago
QNRX
Quoin Pharmaceuticals initiated with a Buy at ThinkEquity
PremiumThe Fly
Quoin Pharmaceuticals initiated with a Buy at ThinkEquity
3M ago
QNRX
Quoin Wins Japan Orphan Drug Status for QRX003
PremiumCompany Announcements
Quoin Wins Japan Orphan Drug Status for QRX003
4M ago
8K
QNRX
Quoin Pharmaceuticals granted Orphan Drug Designation for QRX003 in Japan
PremiumThe Fly
Quoin Pharmaceuticals granted Orphan Drug Designation for QRX003 in Japan
4M ago
QNRX
Quoin Pharmaceuticals submits QRX003 IND application to FDA
PremiumThe FlyQuoin Pharmaceuticals submits QRX003 IND application to FDA
4M ago
QNRX
Quoin Pharmaceuticals initiated with a Buy at Lucid Capital
Premium
The Fly
Quoin Pharmaceuticals initiated with a Buy at Lucid Capital
5M ago
QNRX
Quoin Pharmaceuticals provides regulatory update on QRX009 topical rapamycin
Premium
The Fly
Quoin Pharmaceuticals provides regulatory update on QRX009 topical rapamycin
5M ago
QNRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >